iShares US Healthcare Providers

Most Recent

  • How Can Changing Demographics Impact Investors?
    Macroeconomic Analysis

    How Can Changing Demographics Impact Investors?

    Changing demographics impact investors in many ways. The demand for bonds could increase, putting downward pressure on yields.

    By Rick Rieder
  • uploads///Chart
    Miscellaneous

    Squire Study Supports Portrazza’s Approval

    The FDA approved Portrazza for the treatment of squamous NSCLC based on the results of a phase III study named Squire.

    By Mike Benson
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Express Scripts Trades Above Its 100-Day Moving Average

    Express Scripts Holdings rose 0.4%. The company was in the news on November 10 when it announced that it would remove Linden Care Pharmacy from its network.

    By Peter Neil
  • uploads///Graph
    Earnings Report

    Universal Health Services’ Behavioral Health Business in 3Q15

    Universal Health Services (UHS) is expected to benefit from its leading market position in the behavioral health business in 3Q15.

    By Margaret Patrick
  • uploads///Chart
    Company & Industry Overviews

    Decoding Humana’s Revenue Stream in 2015

    Humana reported revenues of about $54.3 billion in its 2015 results. This amounts to a 12% revenue growth in 2015, compared to ~$48.1 billion in 2014.

    By Mike Benson
  • uploads///part
    Company & Industry Overviews

    Danaher Corporation’s Excess Returns Fail to Impress

    Earlier in this series, we looked at Danaher’s return on invested capital on a standalone basis. However, we were only looking at half the story.

    By Shannon Black
  • uploads///danaher environmental margins
    Company & Industry Overviews

    Danaher’s Environmental Segment Is a Cut above the Rest

    Danaher’s Environmental & Applied Solutions unit was responsible for 25% of the company’s sales in 2015.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    Introducing Danaher: A Diversified Healthcare Company

    Danaher is a diversified conglomerate with a market cap of ~$56 billion. Its customers are mostly professionals and organizations rather than retail consumers.

    By Shannon Black
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Adeptus Health Leads the Small-Cap Space with 3.6% Gain

    Adeptus Health (ADPT) rose by 3.6% on November 10, 2015. The stock rose following its announcement that it had officially opened its first Texas hospital.

    By Peter Neil
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    Inovalon Gains 2.1%, to Present at NASDAQ Investor Program

    Inovalon closed at $18.26 and was trading below 20-, 50-, and 100-day moving averages.

    By Peter Neil
  • uploads///Graph
    Earnings Report

    Centene’s Hunt for New Growth Opportunities in Existing Markets

    Centene believes that if all its existing markets adopt Medicaid expansion, it would result in 4 million additional members becoming eligible for Medicaid.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    How Does UHS’s Valuation Compare to Other Hospital Companies?

    On February 26, 2016, Universal Health Services (UHS) was trading at a forward PE (price-to-earnings) multiple of about 13.8x.

    By Margaret Patrick
  • uploads///part
    Earnings Report

    Danaher to Declare Its First Earnings after Fortive Separation

    Danaher Corporation (DHR), which became a diversified healthcare company after its restructuring actions, is slated to declare its 3Q16 earnings on October 20. The consensus Wall Street estimate is for Danaher to post adjusted EPS of $0.83 on sales of ~$4.1 billion.

    By Shannon Black
  • uploads///jacobs engineering guidance
    Earnings Report

    How Does Jacobs Engineering Look for Fiscal 2017?

    In the 4Q16 earnings call, Jacobs Engineering provided its initial guidance for the adjusted EPS and a brief overview of the prevailing market conditions.

    By Shannon Black
  • uploads///Graph Part  Oct
    Company & Industry Overviews

    Community Health System Plummets 35.3%, IHF Lost ~6.4%

    Community Health Systems (CYH) fell by 35.3% on October 22, 2015, the biggest fall of the day in the iShares US Healthcare Providers ETF’s portfolio.

    By Peter Neil
  • uploads///Sharpe Ratio Example
    Financials

    Sharpe ratio shows healthcare ETFs are a strong relative investment

    Adjusting performance on a risk basis As new insurees flood the insurance market and baby boomers approach retirement, the healthcare space should expect dramatic increases in demand. Alongside an increase in demand, however, has been a tightening of reimbursement policy and a more stringent regulatory environment. These variables present unique risks and opportunities for healthcare […]

    By Amritpal Khalsa
  • uploads///human skeleton _
    Company & Industry Overviews

    United Health Group Stock Has Risen 28% in 2018

    On November 29, United Health Group’s (UNH) stock price closed at $282.55, which is ~8% growth from its close of $261.62 on November 23.

    By Daniel Collins
  • uploads///REV EPS GROWTH ESRX
    Miscellaneous

    Express Scripts: How Its Performance Contributed to Its Valuation

    Express Scripts’ (ESRX) revenue fell 1% in both 2016 and the first nine months of 2017.

    By Amanda Lawrence
  • uploads///Graph
    Miscellaneous

    Hospital Industry Reacts to the Failed Healthcare Bill

    On March 24, 2017, House Speaker Paul Ryan pulled back the American Health Care Act, also known as “Trumpcare,” before votes were cast.

    By Margaret Patrick
  • uploads///segment revenues
    Earnings Report

    How Did Danaher’s Operating Segments Fare in 4Q16?

    Currently, Danaher (DHR) reports its revenue under four operating segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.

    By Sheldon Krieger
  • uploads///stock
    Earnings Report

    Why Danaher Stock Rose after Its 4Q16 Results

    Danaher Corporation (DHR) announced its 4Q16 and 2016 earnings results before the market opened on January 31, 2017. Let’s take a look.

    By Sheldon Krieger
  • uploads///revenue estimates
    Earnings Report

    Behind Danaher’s 4Q16 Revenue Estimates

    Danaher (DHR) reported ~$5.9 billion in consolidated revenue in 4Q15. Analysts expect DHR to report $4.5 billion in 4Q16 revenue.

    By Sheldon Krieger
  • uploads///stock price
    Earnings Report

    What Factors Could Drive Danaher Stock in 2017?

    Danaher Corporation (DHR) will announce its 4Q16 earning results before the market opens on January 31, 2017. What should we expect?

    By Sheldon Krieger
  • uploads///danaher acquires cepheid
    Healthcare

    What Made Cepheid Attractive to Danaher?

    On September 6, 2016, Danaher (DHR) announced that it has entered into a definitive agreement to acquire Cepheid (CPHD) for $4 billion.

    By Shannon Black
  • uploads///danaher dental sales
    Company & Industry Overviews

    Danaher’s Dental Unit Enjoys These Competitive Advantages

    Danaher’s Dental segment is a $2.7 billion business.

    By Shannon Black
  • uploads///danaher diagnostics competitors
    Company & Industry Overviews

    How Danaher Diagnostics Fares against Its Competition

    Danaher’s Diagnostics unit had operating margins of 15.4% in 2015 and 17.2% in 1H16.

    By Shannon Black
  • uploads///danaher pall recurring
    Company & Industry Overviews

    The Key Product Lines That Make Up Danaher’s Diagnostics Business

    Danaher’s (DHR) Diagnostics unit, established through the acquisition of Radiometer in 2004, earned $4.9 billion in sales in 2015.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    How Are Danaher’s Returns Compared to Its Industry Peers’?

    Danaher’s ROIC fell steadily from 15.5% in 2006 to 8.5% in 2015, indicating that it has probably had fewer high return reinvestment opportunities since then.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    Why 3M Sees an Opportunity in Tier B Chinese Hospitals

    20% of 3M Company’s (MMM) Healthcare sales are derived from developing economies, which have been growing organically since 2012.

    By Shannon Black
  • uploads///part
    Company & Industry Overviews

    How 3M Company’s Products Look After Your Health

    Revenues from 3M Company’s (MMM) Healthcare segment rose from 16.7% ($5 billion) of total annual revenue in 2011 to 17.5% ($5.4 billion) in 2015.

    By Shannon Black
  • uploads///Graph
    Earnings Report

    LabCorp Trades at Discounted PE Multiples Compared with Peers in 1Q16

    In a survey of 22 brokerage companies on April 26, 2016, about 71.4% of the brokers rated LabCorp (LH) a “buy,” while 28.6% rated it a “hold.” None of the brokers rated it a “sell.”

    By Margaret Patrick
  • uploads///Graph
    Earnings Report

    HCA Holdings’s Operating Expense Ratio Fell in 4Q15

    In 4Q15, HCA Holdings spent about $8.1 billion on salaries, supplies, and other operating expenses combined—an increase of 5.3% from $7.7 billion spent in 4Q14.

    By Margaret Patrick
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    IHF’s Large-Cap Stocks Gave Positive Returns

    The large-cap stocks of the iShares US Healthcare Providers ETF (IHF) rose marginally with a return of 0.35%. They outperformed IHF and SPY.

    By Peter Neil
  • uploads///Graph Part  Dec
    Company & Industry Overviews

    IHF Sustains the Biotech Sell-off, Loses Marginally

    The sell-off that took down one of the days last week weighed heavily on biotechs. The iShares US Healthcare Providers ETF (IHF) was the best-performing biotech ETF, and the SPDR S&P Biotech ETF (XBI) was the worst.

    By Peter Neil
  • uploads///Chart
    Miscellaneous

    FDA Approves Eli Lilly’s Portrazza Based on Squire Study

    The FDA has approved Eli Lilly’s Portrazza, the first biologic to get approval as a first-line treatment for patients with metastatic squamous NSCLC.

    By Mike Benson
  • uploads///Graph Part  Nov
    Company & Industry Overviews

    UnitedHealth Declares Dividend, Stock Rises

    UnitedHealth Group rose 1.4% on November 10, 2015. The company announced a dividend of $0.5 per share to be paid on December 15, 2015.

    By Peter Neil
  • uploads///Graph Part  Oct
    Company & Industry Overviews

    Team Health Led the Mid-Cap Space with 10.1% Gains

    Team Health Holdings (TMH) rose by 10.1% for the week ending October 23, 2015. The stock rose as it announced preliminary numbers for 3Q15.

    By Peter Neil
  • uploads///Graph
    Earnings Report

    What Are UnitedHealth Group’s Growth Opportunities?

    To strengthen their presence in international markets, health insurance companies have been involved in mergers and acquisitions with local insurance companies in these markets.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.